Freezing tumors to boost immune attack on spreading cancer
NCT ID NCT04701918
Summary
This study tested whether freezing one tumor site (cryoablation) could help the body's immune system work better when combined with immunotherapy drugs (pembrolizumab or avelumab) for people with advanced bladder cancer that has spread. The goal was to see if this combination could shrink other tumors in the body. It involved a small group of patients and aimed to measure tumor response and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.